Recent News

• 07.18.2025 - HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock
• 07.18.2025 - HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock
• 07.18.2025 - HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock
• 02.20.2025 - HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”)
• 02.20.2025 - HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”)
• 01.30.2025 - HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
• 01.30.2025 - HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV

Recent Filings

• 07.03.2025 - DEFM14A Definitive proxy statement relating to merger or acquisition
• 06.30.2025 - PRER14A Preliminary Proxy Soliciting materials
• 06.16.2025 - PREM14A Preliminary proxy statements relating to merger or acquisition
• 06.04.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 05.22.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 05.22.2025 - 8-K Current report
• 05.15.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 04.30.2025 - 10-K/A Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.28.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.20.2025 - EX-99.1 EX-99.1